| 000 | 01404 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513192112.0 | ||
| 264 | 0 | _c19990929 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHebib, N C | |
| 245 | 0 | 0 |
_aPeripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles. _h[electronic resource] |
| 260 |
_bBlood _cSep 1999 |
||
| 300 |
_a1803-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aHematologic Neoplasms _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
| 650 | 0 | 4 | _aTransplantation Immunology |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _afas Receptor |
| 700 | 1 | _aDéas, O | |
| 700 | 1 | _aRouleau, M | |
| 700 | 1 | _aDurrbach, A | |
| 700 | 1 | _aCharpentier, B | |
| 700 | 1 | _aBeaujean, F | |
| 700 | 1 | _aVernant, J P | |
| 700 | 1 | _aSenik, A | |
| 773 | 0 |
_tBlood _gvol. 94 _gno. 5 _gp. 1803-13 |
|
| 999 |
_c10435128 _d10435128 |
||